Results 231 to 240 of about 78,435,061 (269)
T‐Cell Response After SARS‐CoV‐2 Vaccination in Patients With Hematological Malignancy
ABSTRACT Patients with hematologic malignancies (HM) often mount poor humoral responses to SARS‐CoV‐2 vaccination due to their immunocompromised status. Protection against severe COVID‐19 is strongly related to cellular immunity, yet vaccine‐induced T‐cell responses remain incompletely characterized.
L. S. Boerenkamp +7 more
wiley +1 more source
Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome. [PDF]
Brīvība M +11 more
europepmc +1 more source
Using 1H NMR metabolomics, we measured polar and lipid metabolites from human blood neutrophils from people with frailty (n = 31, mean age 84Y), people with rheumatoid arthritis (n = 16, mean age 55Y), robust older (n = 24, mean age 66Y) and healthy younger people (n = 21, mean age 22Y).
Genna Ali Abdullah +5 more
wiley +1 more source
RNA and DNA viruses can manipulate host cell death through various mechanisms. RNA viruses (H1N1, SARS‐CoV‐2) induce acute apoptosis, necroptosis, and pyroptosis to promote rapid viral transmission and epithelial barrier damage. In contrast, DNA viruses (HSV‐1, EBV) regulate these mechanisms to sustain a lytic‐latency cycle, evade immune response and ...
Panagiotis Keramidas +4 more
wiley +1 more source
ABSTRACT Drawing on Gendered Opportunity Structures Theory (Ely and Meyerson), this cross‐national qualitative study examines how formal policies, informal practices, and symbolic cultural narratives jointly configure employer support across three phases of the maternity transition—before leave, during leave, and after leave—in Brazil and the United ...
Letícia Maria Barbano +1 more
wiley +1 more source
Abstract Introduction Human immunodeficiency virus (HIV) is a rare cause of autoimmune haemolytic anaemia (AIHA) which requires prompt diagnosis and treatment. We compared clinical and laboratory findings in AIHA patients with and without HIV. Methods We included adults with severe AIHA (haemoglobin ≤8 g/dL) diagnosed at a tertiary academic centre ...
Kathleen O. De John +4 more
wiley +1 more source
Abstract Introduction The coronavirus disease 2019 (COVID‐19) pandemic substantially affected healthcare systems worldwide and may have compromised access to human immunodeficiency virus (HIV) prevention strategies, including post‐exposure prophylaxis (HIV‐PEP).
Matheus Negri Boschiero +2 more
wiley +1 more source
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley +15 more
wiley +1 more source

